Loading...
Vaccine
India Pharmaceutical Trade Intelligence
Who Supplies Vaccine to India from ITALY
India's vaccine imports from ITALY total $1.7B across 161 shipments from 6 foreign suppliers. GLAXOSMITHKLINE BIOLOGICALS SA leads with $1.7B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for vaccine — a diversified sourcing base with multiple active suppliers from ITALY.
Top foreign suppliers (ITALY) — Ranked by import value
GLAXOSMITHKLINE BIOLOGICALS SA is the leading Vaccine supplier from ITALY to India, with import value of $1.7B across 9 shipments. The top 5 suppliers — GLAXOSMITHKLINE BIOLOGICALS SA, FATRO.S.P.A., FATRO S P A, FATRO S.P.A., BOEHRINGER INGELHEIM VETMEDICA GMBH — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (ITALY)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE BIOLOGICALS SA | $1.7B | 9 | 99.9% |
| 2 | FATRO.S.P.A. | $1.2M | 97 | 0.1% |
| 3 | FATRO S P A | $493.6K | 14 | 0.0% |
| 4 | FATRO S.P.A. | $295.2K | 28 | 0.0% |
| 5 | BOEHRINGER INGELHEIM VETMEDICA GMBH | $172.9K | 12 | 0.0% |
| 6 | NEWLIFE BIOPHARMA LIMITED | $14.5K | 1 | 0.0% |
Showing top 6 of 6 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from ITALY)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | $1.7B | 9 | 99.9% |
| 2 | STALLEN SOUTH ASIA PRIVATE LIMITED. | $1.3M | 105 | 0.1% |
| 3 | STALLEN SOUTH ASIA PRIVATE LIMITED | $675.1K | 34 | 0.0% |
| 4 | BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED | $172.9K | 12 | 0.0% |
| 5 | ZYDUS LIFESCIENCES LIMITED | $14.5K | 1 | 0.0% |
Import Statistics
- Import Value
- $1.7B
- Shipments
- 161
- Foreign Suppliers
- 6
- Indian Buyers
- 5
- Avg. Shipment
- $10.7M
Other Vaccine Import Origins
Frequently Asked Questions — Vaccine Imports from ITALY
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Vaccine suppliers from ITALY to India?
The top Vaccine suppliers from ITALY to India include GLAXOSMITHKLINE BIOLOGICALS SA, FATRO.S.P.A., FATRO S P A. The leading supplier is GLAXOSMITHKLINE BIOLOGICALS SA with import value of $1.7B USD across 9 shipments. India imported Vaccine worth $1.7B USD from ITALY in total across 161 shipments.
QHow much Vaccine does India import from ITALY?
India imported Vaccine worth $1.7B USD from ITALY across 161 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Vaccine from ITALY?
The main Indian buyers of Vaccine sourced from ITALY include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, STALLEN SOUTH ASIA PRIVATE LIMITED., STALLEN SOUTH ASIA PRIVATE LIMITED. The largest buyer is GLAXOSMITHKLINE PHARMACEUTICALS LIMITED with $1.7B in imports across 9 shipments.
QWhat is the total value of Vaccine imports from ITALY to India?
The total value of Vaccine imports from ITALY to India is $1.7B USD, across 161 shipments and 6 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: ITALY to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Vaccine.
- 2.Supplier/Buyer Matching: 6 foreign suppliers from ITALY and 5 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $1.7B aggregated from 161 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
161 Verified Shipments
6 suppliers, 5 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists